Enzyme Finance(MLN)Asset management
$18.41
24h:
+0.59%
7d:
+0.81%
30d:
-9.29%
180d:
-13.17%
ATH:
$258.26
ATL:
$1.79
Market cap (circulating)
$26.77m
-7.54%
Revenue (30d)
Market cap (fully diluted)
$38.09m
-7.83%
Revenue (annualized)
Total value locked
$77.30m
+1.55%
P/F ratio (fully diluted)
Capital deployed (annualized)
P/S ratio (fully diluted)
Fees (30d)
Treasury
Fees (annualized)
Active users (daily) (30d average)
Core developers (30d average)
Code commits (30d sum)
About
What is Enzyme Finance
Enzyme Finance is an asset management protocol built on Ethereum. Enzyme Finance was founded by Mona El Isa and launched in 2016.
How does Enzyme Finance work
Liquidity providers deposit funds into Enzyme Finance and receive return on investment (supply-side fees).
Who governs Enzyme Finance
MLN tokenholders own and govern the protocol. They currently take a cut of the total return on investment, total assets under management & entrance fees paid by liquidity providers (revenue). Enzyme Finance’s investors include KR1, etc.
Key metrics
Daily market cap (fully diluted) vs. daily total value locked in the past 180 days.
Metrics
| Growth rate | 24h | 7d | 30d | 90d | 180d | 365d |
|---|---|---|---|---|---|---|
| Market cap (fully diluted) | +0.7% | +2.1% | -7.8% | -26.9% | -13.2% | -34.8% |
| Total value locked | +0.6% | +5.1% | +1.6% | +7.5% | +95.9% | -36.2% |